Other Assets, Noncurrent in USD of ACADIA PHARMACEUTICALS INC from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
ACADIA PHARMACEUTICALS INC quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • ACADIA PHARMACEUTICALS INC Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $2.99M, a 734% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

ACADIA PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.99M +$2.64M +734% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $2.25M +$1.78M +373% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $1.46M +$979K +206% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $359K -$117K -24.6% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $359K -$116K -24.4% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $476K -$10.8M -95.8% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $476K -$12M -96.2% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $476K -$7.11M -93.7% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $475K -$5.57M -92.1% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 $11.3M +$7.46M +194% 30 Jun 2023 10-Q 03 Aug 2023
Q1 2023 $12.4M +$8.1M +187% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 $7.59M +$3.59M +89.8% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $6.04M +$3.67M +155% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $3.84M +$1.85M +92.7% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $4.34M +$2.52M +139% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $4M +$2.32M +138% 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $2.37M +$828K +53.6% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $1.99M +$261K +15.1% 30 Jun 2021 10-Q 05 Aug 2021
Q1 2021 $1.81M +$471K +35.1% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $1.68M -$1.18M -41.3% 31 Dec 2020 10-K 01 Mar 2022
Q3 2020 $1.55M -$762K -33% 30 Sep 2020 10-Q 04 Nov 2020
Q2 2020 $1.73M +$143K +9.01% 30 Jun 2020 10-Q 06 Aug 2020
Q1 2020 $1.34M -$223K -14.2% 31 Mar 2020 10-Q 08 May 2020
Q4 2019 $2.86M +$958K +50.4% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $2.31M +$881K +61.8% 30 Sep 2019 10-Q 31 Oct 2019
Q2 2019 $1.59M -$1.61M -50.3% 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 $1.57M +$1.24M +385% 31 Mar 2019 10-Q 02 May 2019
Q4 2018 $1.9M +$1.55M +436% 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 $1.43M +$1.06M +286% 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $3.19M +$2.67M +512% 30 Jun 2018 10-Q 08 Aug 2018
Q1 2018 $323K -$345K -51.6% 31 Mar 2018 10-Q 04 May 2018
Q4 2017 $354K -$431K -54.9% 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 $369K -$606K -62.2% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 $522K -$589K -53% 30 Jun 2017 10-Q 08 Aug 2017
Q1 2017 $668K -$572K -46.1% 31 Mar 2017 10-Q 09 May 2017
Q4 2016 $785K +$456K +139% 31 Dec 2016 10-K 27 Feb 2018
Q3 2016 $975K +$570K +141% 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 $1.11M +$778K +234% 30 Jun 2016 10-Q 04 Aug 2016
Q1 2016 $1.24M +$962K +346% 31 Mar 2016 10-Q 05 May 2016
Q4 2015 $329K +$42K +14.6% 31 Dec 2015 10-K 28 Feb 2017
Q3 2015 $405K +$227K +128% 30 Sep 2015 10-Q 05 Nov 2015
Q2 2015 $333K +$222K +200% 30 Jun 2015 10-Q 06 Aug 2015
Q1 2015 $278K +$135K +94.4% 31 Mar 2015 10-Q 07 May 2015
Q4 2014 $287K +$108K +60.3% 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 $178K +$58K +48.3% 30 Sep 2014 10-Q 10 Nov 2014
Q2 2014 $111K +$55K +98.2% 30 Jun 2014 10-Q 05 Aug 2014
Q1 2014 $143K 31 Mar 2014 10-Q 06 May 2014
Q4 2013 $179K 31 Dec 2013 10-K 26 Feb 2015
Q3 2013 $120K +$118K +5900% 30 Sep 2013 10-Q 06 Nov 2013
Q2 2013 $56K +$49K +700% 30 Jun 2013 10-Q 06 Aug 2013
Q3 2012 $2K -$76K -97.4% 30 Sep 2012 10-Q 05 Nov 2012
Q2 2012 $7K -$79K -91.9% 30 Jun 2012 10-Q 08 Aug 2012
Q1 2012 $11K 31 Mar 2012 10-Q 08 May 2012
Q4 2011 $14K -$105K -88.2% 31 Dec 2011 10-K 12 Mar 2013
Q3 2011 $78K 30 Sep 2011 10-Q 09 Nov 2011
Q2 2011 $86K 30 Jun 2011 10-Q 10 Aug 2011
Q4 2010 $119K 31 Dec 2010 10-K 06 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.